_id

690db127ccc777a4e85d0bd3

Ticker

ARVN

Name

Arvinas Inc

Exchange

NASDAQ

Address

5 Science Park, New Haven, CT, United States, 06511

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.arvinas.com

Description

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.

Last Close

12.57

Volume

1689336

Current Price

12.58

Change

0.07955449482895614

Last Updated

2025-11-28T12:24:28.621Z

Image

data:image/webp;base64,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

Ipo Date

2018-09-27T00:00:00.000Z

Market Cap

911846528

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.42425

Sentiment Sources

8

Rating

4.0476

Target Price

12.3125

Strong Buy

9

Buy

4

Hold

8

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

41900000

Cost Of Revenue

-

Gross Profit

41900000

Operating Expenses

85700000

Operating Income

-43800000

Interest Expense

-

Pretax Income

-34800000

Net Income

-35100000

Eps

-0.48148148148148145

Dividends Per Share

-

Shares Outstanding

64224294

Income Tax Expense

300000

EBITDA

-34000000

Operating Margin

-104.5346062052506

Total Other Income Expense Net

9000000

Cash

101500000

Short Term Investments

686100000

Receivables

26800000

Inventories

-

Total Current Assets

826300000

Property Plant Equipment

14100000

Total Assets

844300000

Payables

17800000

Short Term Debt

1900000

Long Term Debt

400000

Total Liabilities

279900000

Equity

564400000

Depreciation

1300000

Change In Working Capital

-32799999

Cash From Operations

-59100000

Capital Expenditures

100000

Cash From Investing

63500000

Cash From Financing

-17800000

Net Change In Cash

-13400000

PE

-

PB

1.624879518072289

ROE

-6.218993621545003

ROA

-4.157290062773895

FCF

-59200000

Fcf Percent

-1.4128878281622912

Piotroski FScore

0

Health Score

34

Deep Value Investing Score

4

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

4.5

Growth Investing Score

3

Momentum Investing Score

5

Net Net Investing Score

1

Quality Investing Score

3

Value Investing Score

5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

41900000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

41900000

Quarters > 0 > income Statement > operating Expenses

85700000

Quarters > 0 > income Statement > operating Income

-43800000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-34800000

Quarters > 0 > income Statement > net Income

-35100000

Quarters > 0 > income Statement > eps

-0.48148148148148145

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

72900000

Quarters > 0 > income Statement > income Tax Expense

300000

Quarters > 0 > income Statement > EBITDA

-34000000

Quarters > 0 > income Statement > operating Margin

-104.5346062052506

Quarters > 0 > income Statement > total Other Income Expense Net

9000000

Quarters > 0 > balance Sheet > cash

101500000

Quarters > 0 > balance Sheet > short Term Investments

686100000

Quarters > 0 > balance Sheet > receivables

26800000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

826300000

Quarters > 0 > balance Sheet > property Plant Equipment

14100000

Quarters > 0 > balance Sheet > total Assets

844300000

Quarters > 0 > balance Sheet > payables

17800000

Quarters > 0 > balance Sheet > short Term Debt

1900000

Quarters > 0 > balance Sheet > long Term Debt

400000

Quarters > 0 > balance Sheet > total Liabilities

279900000

Quarters > 0 > balance Sheet > equity

564400000

Quarters > 0 > cash Flow > net Income

-35100000

Quarters > 0 > cash Flow > depreciation

1300000

Quarters > 0 > cash Flow > change In Working Capital

-32799999

Quarters > 0 > cash Flow > cash From Operations

-59100000

Quarters > 0 > cash Flow > capital Expenditures

100000

Quarters > 0 > cash Flow > cash From Investing

63500000

Quarters > 0 > cash Flow > cash From Financing

-17800000

Quarters > 0 > cash Flow > net Change In Cash

-13400000

Quarters > 0 > ratios > PE

-0.48148148148148145

Quarters > 0 > ratios > PB

1.624879518072289

Quarters > 0 > ratios > ROE

-6.218993621545003

Quarters > 0 > ratios > ROA

-4.157290062773895

Quarters > 0 > ratios > FCF

-59200000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-1.4128878281622912

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

22400000

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

22400000

Quarters > 1 > income Statement > operating Expenses

93900000

Quarters > 1 > income Statement > operating Income

-71500000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-61500000

Quarters > 1 > income Statement > net Income

-61200000

Quarters > 1 > income Statement > eps

-0.8383561643835616

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

73000000

Quarters > 1 > income Statement > income Tax Expense

-300000

Quarters > 1 > income Statement > EBITDA

-70100000

Quarters > 1 > income Statement > operating Margin

-319.19642857142856

Quarters > 1 > income Statement > total Other Income Expense Net

10000000

Quarters > 1 > balance Sheet > cash

114900000

Quarters > 1 > balance Sheet > short Term Investments

746300000

Quarters > 1 > balance Sheet > receivables

11100000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

889500000

Quarters > 1 > balance Sheet > property Plant Equipment

15400000

Quarters > 1 > balance Sheet > total Assets

909300000

Quarters > 1 > balance Sheet > payables

16600000

Quarters > 1 > balance Sheet > short Term Debt

1800000

Quarters > 1 > balance Sheet > long Term Debt

500000

Quarters > 1 > balance Sheet > total Liabilities

300000000

Quarters > 1 > balance Sheet > equity

609300000

Quarters > 1 > cash Flow > net Income

-61200000

Quarters > 1 > cash Flow > depreciation

1400000

Quarters > 1 > cash Flow > change In Working Capital

-42800000

Quarters > 1 > cash Flow > cash From Operations

-95400000

Quarters > 1 > cash Flow > capital Expenditures

1200000

Quarters > 1 > cash Flow > cash From Investing

128800000

Quarters > 1 > cash Flow > cash From Financing

500000

Quarters > 1 > cash Flow > net Change In Cash

33900000

Quarters > 1 > ratios > PE

-0.8383561643835616

Quarters > 1 > ratios > PB

1.5072049893320205

Quarters > 1 > ratios > ROE

-10.044313146233383

Quarters > 1 > ratios > ROA

-6.730451996040911

Quarters > 1 > ratios > FCF

-96600000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-4.3125

Quarters > 1 > health Score

34

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

188800000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

188800000

Quarters > 2 > income Statement > operating Expenses

117400000

Quarters > 2 > income Statement > operating Income

71400000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

83100000

Quarters > 2 > income Statement > net Income

82900000

Quarters > 2 > income Statement > eps

1.1403026134800551

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

72700000

Quarters > 2 > income Statement > income Tax Expense

200000

Quarters > 2 > income Statement > EBITDA

72700000

Quarters > 2 > income Statement > operating Margin

37.81779661016949

Quarters > 2 > income Statement > total Other Income Expense Net

11700000

Quarters > 2 > balance Sheet > cash

81000000

Quarters > 2 > balance Sheet > short Term Investments

873300000

Quarters > 2 > balance Sheet > receivables

8400000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

979700000

Quarters > 2 > balance Sheet > property Plant Equipment

16600000

Quarters > 2 > balance Sheet > total Assets

1001100000

Quarters > 2 > balance Sheet > payables

26400000

Quarters > 2 > balance Sheet > short Term Debt

1900000

Quarters > 2 > balance Sheet > long Term Debt

500000

Quarters > 2 > balance Sheet > total Liabilities

341000000

Quarters > 2 > balance Sheet > equity

660100000

Quarters > 2 > cash Flow > net Income

82900000

Quarters > 2 > cash Flow > depreciation

1300000

Quarters > 2 > cash Flow > change In Working Capital

-187600000

Quarters > 2 > cash Flow > cash From Operations

-88900000

Quarters > 2 > cash Flow > capital Expenditures

400000

Quarters > 2 > cash Flow > cash From Investing

69500000

Quarters > 2 > cash Flow > cash From Financing

-100000

Quarters > 2 > cash Flow > net Change In Cash

-19500000

Quarters > 2 > ratios > PE

1.1403026134800551

Quarters > 2 > ratios > PB

1.3854961369489471

Quarters > 2 > ratios > ROE

12.558703226783821

Quarters > 2 > ratios > ROA

8.280891019878133

Quarters > 2 > ratios > FCF

-89300000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

-0.4729872881355932

Quarters > 2 > health Score

63

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

59200000

Quarters > 3 > income Statement > cost Of Revenue

1600000

Quarters > 3 > income Statement > gross Profit

59200000

Quarters > 3 > income Statement > operating Expenses

117400000

Quarters > 3 > income Statement > operating Income

-58200000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-45500000

Quarters > 3 > income Statement > net Income

-45100000

Quarters > 3 > income Statement > eps

-0.6255201109570042

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

72100000

Quarters > 3 > income Statement > income Tax Expense

-400000

Quarters > 3 > income Statement > EBITDA

-56600000

Quarters > 3 > income Statement > operating Margin

-98.3108108108108

Quarters > 3 > income Statement > total Other Income Expense Net

12700000

Quarters > 3 > balance Sheet > cash

100500000

Quarters > 3 > balance Sheet > short Term Investments

938900000

Quarters > 3 > balance Sheet > receivables

13700000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

1067300000

Quarters > 3 > balance Sheet > property Plant Equipment

16000000

Quarters > 3 > balance Sheet > total Assets

1091400000

Quarters > 3 > balance Sheet > payables

13400000

Quarters > 3 > balance Sheet > short Term Debt

1800000

Quarters > 3 > balance Sheet > long Term Debt

600000

Quarters > 3 > balance Sheet > total Liabilities

529700000

Quarters > 3 > balance Sheet > equity

561700000

Quarters > 3 > cash Flow > net Income

-45100000

Quarters > 3 > cash Flow > depreciation

1600000

Quarters > 3 > cash Flow > change In Working Capital

-60200000

Quarters > 3 > cash Flow > cash From Operations

-84100000

Quarters > 3 > cash Flow > capital Expenditures

300000

Quarters > 3 > cash Flow > cash From Investing

98900000

Quarters > 3 > cash Flow > cash From Financing

500000

Quarters > 3 > cash Flow > net Change In Cash

15300000

Quarters > 3 > ratios > PE

-0.6255201109570042

Quarters > 3 > ratios > PB

1.6147730105038278

Quarters > 3 > ratios > ROE

-8.02919708029197

Quarters > 3 > ratios > ROA

-4.1323071284588595

Quarters > 3 > ratios > FCF

-84400000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-1.4256756756756757

Quarters > 3 > health Score

30

Valuation > metrics > PE

-0.48148148148148145

Valuation > metrics > PB

1.624879518072289

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-6.218993621545003

Profitability > metrics > ROA

-4.247851869780951

Profitability > metrics > Net Margin

-0.837708830548926

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.4959248759744862

Risk > metrics > Interest Coverage

-54.75

Risk > final Score

-159

Risk > verdict

High

Liquidity > metrics > Current Ratio

41.944162436548226

Liquidity > metrics > Quick Ratio

41.944162436548226

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

100

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

81

Prev Profitabilities > 2

0

Prev Risks > 0

27

Prev Risks > 1

75

Prev Risks > 2

27

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:14:31.807Z